26 Jul ExCellThera

Posted at 18:36h in by Brittany Miller

David Millette, CEO

Oct. 7 | 3:15pm | FLW Ballroom F

Montreal, Canada

(Private)

ExCellThera is a late-stage biotechnology company focused on advancing next-generation cell therapies. Its lead product, Zemcelpro®, is a patented, one-time curative treatment designed for patients with hematologic malignancies who face limited or ineffective therapeutic options. This includes individuals without suitable donors or those with high-risk malignancies that respond poorly to stem cell transplants. Zemcelpro recently received a positive opinion from the European Medicines Agency (EMA), positioning it for marketing authorization and initial commercial launch in the second half of 2025.

www.excellthera.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,500 attendees – over 30% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 5-7, 2026
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions